The Discounted Cash Flow (DCF) valuation of Plus Therapeutics Inc (PSTV) is (3.37) USD. With the latest stock price at 0.30 USD, the upside of Plus Therapeutics Inc based on DCF is -1237.0%.
Based on the latest price of 0.30 USD and our DCF valuation, Plus Therapeutics Inc (PSTV) is a sell. selling PSTV stocks now will result in a potential gain of 1237.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.1% - 7.4% | 6.3% |
| Long-term Growth Rate | 3.0% - 4.7% | 3.9% |
| Fair Price | (22.06) - (1.88) | (3.37) |
| Upside | -7543.2% - -734.4% | -1237.0% |